Autopsy report · NCT00294437
ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
Cause of deathFunding or business
“underfunding”
Life of this trial
- Registered 2 years 2 months after it had already started.
- Ran for about 3 years 11 months before it stopped.
- 376 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Central European Cooperative Oncology Group
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- Zometa
- Participants
- 376
- Sites
- 57
- Countries
- Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Estonia, Hungary, Lithuania, Montenegro, Poland, Romania, Russia and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.